Article
The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Health Care Setting.
Thyroid : official journal of the American Thyroid Association - 1 Sept 2020
Chen Tanya, Gilfix Brian M, Rivera Juan, Sadeghi Nader, Richardson Keith, Hier Michael P, Forest Véronique-Isabelle, Fishman Dina, Caglar Derin, Pusztaszeri Marc, Mitmaker Elliot Jonathan, Payne Richard J
Abstract excerpt
Background: Although the current gold standard for diagnosing thyroid nodule malignancy is ultrasound-guided fine-needle aspiration (FNA) cytology, about 20-25% of cytological evaluations are considered indeterminate for malignancy. This limitation has led to the emergence of next-generation sequencing panels, for example, ThyroSeq v3 (TSv3), which recognize highly diagnostic genetic mutations of common thyroid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.